The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PDL1 status in muscle-invasive urothelial carcinoma in the context of neoadjuvant cisplatin-based chemotherapy.
 
Jen-Jane Liu
No Relationships to Disclose
 
Alexander S Baras
No Relationships to Disclose
 
Nilay M Gandhi
No Relationships to Disclose
 
Gunes Guner
No Relationships to Disclose
 
Enrico Munari
No Relationships to Disclose
 
Sheila Faraj
No Relationships to Disclose
 
Janis M. Taube
No Relationships to Disclose
 
Mark Schoenberg
No Relationships to Disclose
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Speakers' Bureau - Medivation
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Fluidigm (Inst); Genentech/Roche (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bionomics; Millennium
 
Charles G. Drake
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck; Novartis; Roche
 
George J. Netto
No Relationships to Disclose
 
Trinity Bivalacqua
No Relationships to Disclose